Jian Rui Wang

Title: Innovations of Jian Rui Wang

Introduction

Jian Rui Wang is an accomplished inventor based in San Jose, California. He has made significant contributions to the field of biotechnology, particularly in the development of methods and compositions concerning antibodies that bind CD84-like polypeptides. With a total of two patents to his name, Wang's work has the potential to impact therapeutic approaches in cancer treatment.

Latest Patents

Wang's latest patents include innovative methods and compositions that focus on antibodies binding to CD84-like polypeptides. The first patent provides novel polynucleotides and polypeptides encoded by these polynucleotides, which correspond to a newly identified human secreted CD84-like polypeptide. These polynucleotides consist of nucleic acid sequences isolated from a cDNA library derived from human spleen. The second patent describes methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells, particularly in cancer types such as lymphomas. This method utilizes CD84Hy1 polypeptides, nucleic acids encoding for these polypeptides, and anti-CD84Hy1 antibodies to target and inhibit the growth of cancer cells expressing the CD84Hy1 protein.

Career Highlights

Throughout his career, Jian Rui Wang has worked with notable companies in the biotechnology sector, including Novelo, Inc. and Arca Biopharma, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for medical challenges.

Collaborations

Wang has collaborated with esteemed colleagues such as Douglas Dedera and Peter Emtage, further enhancing the impact of his work in the field of biotechnology.

Conclusion

Jian Rui Wang's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work in developing methods for targeting cancer cells showcases the potential for innovative therapies in the medical field.